Filtros de búsqueda

Lista de obras de

A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.

artículo científico publicado en 2015

Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia

artículo científico publicado en 2020

Cellular model system to dissect the isoform-selectivity of Akt inhibitors

artículo científico publicado en 2021

Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma

artículo científico publicado en 2020

Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

artículo científico publicado en 2016

Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity

artículo científico publicado en 2019

Epigenetics of gastrointestinal diseases: notes from a workshop

artículo científico publicado en 2018

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma

scientific article published on 07 March 2020

N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma

scientific article published on 28 April 2020

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer

artículo científico publicado en 2019

Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End Joining

scientific article published on 05 April 2020

Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.

artículo científico publicado en 2015

Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience

artículo científico publicado en 2015

TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer

artículo científico publicado en 2020

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda